x
Filter:
Filters applied
- Concise Reviews for Primary-Care Physicians
- Linder, Brian JRemove Linder, Brian J filter
- United States Food and Drug AdministrationRemove United States Food and Drug Administration filter
- 2018 - 2023Remove 2018 - 2023 filter
Concise Reviews for Primary-Care Physicians
1 Results
- Concise review
Evaluation and Treatment of Overactive Bladder in Women
Mayo Clinic ProceedingsVol. 95Issue 2p370–377Published in issue: February, 2020- Rubin Raju
- Brian J. Linder
Cited in Scopus: 25Overactive bladder (OAB) is a symptom complex that includes urinary urgency, frequency, urgency incontinence, and nocturia. It is highly prevalent, affecting up to 12% of the adult population, and can significantly impact quality of life. The diagnosis of OAB is made by history, physical examination, and a urinalysis to rule out underlying infection or other concerning potential etiologies. The need for additional testing is based on the initial evaluation findings, and is recommended in cases of underlying urinary tract infection, microscopic hematuria, obstructive voiding symptoms, and symptoms refractory to previous treatments.